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Background: Few studies have evaluated the associations between respiratory parameters and 
pain in chronic obstructive pulmonary disease (COPD). The purpose of this study is to evaluate the 
differences in respiratory parameters between COPD patients who did and did not have pain.
Methods: In this cross-sectional study respiratory parameters were measured by spirometry 
and the St Georges Respiratory Questionnaire. Patients responded to a single question that asked 
if they were generally bothered by pain.
Results: Of the 100 patients, 45% reported that they were generally bothered by pain. Patients 
who had pain reported a higher number of comorbidities (P , 0.001) and higher breathlessness 
scores (P = 0.003). Physical dimensions of breathlessness were significantly associated with 
pain (P # 0.03). The results of logistic regression analysis determined that a higher number of 
comorbidities (OR = 0.28; P = 0.026) and higher breathlessness scores (OR = 1.03; P = 0.003) 
made significant unique contributions to the prediction of pain group membership.
Conclusions: Comorbidity and breathlessness were risk factors for pain and the physical 
dimensions of breathlessness were associated with pain.
Keywords: COPD, pain, comorbidity, lung function, breathlessness
Introduction
Of patients with advanced chronic obstructive pulmonary disease (COPD), approxi-
mately 94% report breathlessness and 40% report pain.1 In the palliative phases of 
COPD, prevalence rates for breathlessness increase to 95%–98% and for pain to 
68%–72%.2,3 While both of these symptoms are common in COPD, only six studies 
have investigated these two symptoms in the same patients.1–6
Pain has long been recognized as a symptom that includes a variety of sensations 
and multiple dimensions.7 Breathlessness is described as a subjective experience of 
breathing discomfort that consists of qualitatively distinct sensations that vary in 
  intensity.8 Only recently, though, was the multidimensional model of pain applied to the 
symptom of breathlessness.9 In that paper, Lansing et al illustrated how breathlessness 
is a multidimensional construct, similar to pain, which consists of at least three separate 
and distinct qualities, namely “air hunger”, “work”, and “tightness”.9 “Air hunger” is 
the perception of the urge to breath. This fundamental biological drive arises when 
pulmonary ventilation is insufficient. “Work” is perceived as being uncomfortable 
when the work of breathing is increased by high ventilation, by increasing resistance 
to inspiration, weakness of respiratory muscles, or shortened inspiratory muscle length. 
“Tightness” appears to be associated with bronchoconstriction.9,10 Taken together, in 
patients with COPD, bronchoconstriction, airflow limitations, decreased ventilation, and 
Dovepress




open access to scientific and medical research
Open Access Full Text Article
http://dx.doi.org/10.2147/COPD.S28994International Journal of COPD 2012:7
hyperinflation may give rise to the sensations of air hunger, 
increased work of breathing and tightness.9,10
Breathlessness and pain may share common neurophysi-
ological pathways.9 Recent evidence suggests that the ante-
rior insula is a critical structure involved in the perception 
of the emotional aspects of breathlessness and pain. Within 
this paradigm, pain is viewed as a part of the arousal/stress 
system that is characterized by increased sympathetic activa-
tion, which results in an increased respiratory rate.9 In a recent 
study of patients with fibromyalgia,11 patients who were 
taught slow breathing reported decreases in pain intensity.11 
Of note, the use of slow breathing had a greater effect on 
moderate pain than on mild pain.11 This finding suggests that 
breathing rate influences pain intensity.9,11
While information on the relationship between pain inten-
sity and breathlessness is increasing, little is known about the 
relationships between these two symptoms in patients with 
COPD. In one study that evaluated a number of respiratory 
parameters and pain in patients with COPD,5 increases in 
self-reported breathlessness were associated with increases in 
pain (r = −0.22, P , 0.05). In addition, decreases in oxygen 
saturation were associated with increased pain (r = 0.23, 
P , 0.05).5 In a more recent study,6 while no associations 
were found between objective measures of lung function and 
pain intensity, increased breathlessness was associated with 
increased pain intensity (r = 0.26, P , 0.01).
Given the paucity of research on the associations between 
pain and breathlessness in patients with COPD, the purposes 
of this study were to evaluate for differences in subjective (ie, 
breathlessness) and objective (ie, lung function) respiratory 
parameters between COPD patients who did and did not have 
pain, and to evaluate which subjective and objective respira-
tory variables provided unique contributions to explain the 
likelihood of being classified in the pain group at the time of 
enrollment into a pulmonary rehabilitation program.
Methods
Design, sample, and data collection
This cross-sectional study enrolled 136 patients with COPD 
who were recruited between August 2005 and August 2007 
prior to enrollment in a pulmonary rehabilitation program. 
Patients were included if they were: .35 years of age; 
diagnosed with COPD by a pulmonary physician; reported 
symptoms of breathlessness, chronic cough, and sputum 
production; had a FEV1/FVC , 70% and FEV1 , 80% 
predicted; and were able to read and write Norwegian. The 
exclusion criteria for the study were using long-term oxygen 
treatment and unstable heart disease.
Patients were approached in the outpatient clinic and were 
given verbal and written information about the study. Patients 
who were willing to participate signed the informed consent 
and underwent spirometry. In addition, all patients were 
asked to complete a number of self-report questionnaires and 
to return them in a postage paid envelope. After 2 weeks, a 
reminder letter was sent to those who had not returned the 
questionnaires. The study was approved by the hospital unit, 
the Regional Committee for Medical Research Ethics, and 
the Norwegian Social Science Data Services.
Instruments
Demographic characteristics
Patients completed a demographic questionnaire that obtained 
information on age (continuous variable in years), sex (male, 
female), education (primary school, secondary school, and 
university), marital status (married/partnered, unmarried, 
widowed, divorced/separated), employment status (full 
or part time, not employed), smoking (current smoker, 
  previous smoker, never smoked), comorbidities (yes, no), 
and other chronic medical conditions (myocardial infarction, 
angina, stroke, diabetes, cancer, osteoporosis, fibromyalgia, 
chronic pain, rheumatoid arthritis, osteoarthritis, ankylosing 
spondylitis, skeletal/muscle diseases, psychiatric diagnosis, 
gastrointestinal disease, asthma).
Lung function
Spirometry was performed with a Vitalograph Alpha 
  spirometer (Vitalograph Alpha, Lenexa, KS), according 
to published guidelines.12 Forced expiratory volume in 
one   second (FEV1) and forced vital capacity (FVC) were 
measured and the predicted values calculated according to 
a Norwegian reference population.13 FEV1 (L) and FEV1 as 
a percentage of the predicted value (predicted FEV1%) were 
used as a measure of lung function.
Disease severity
Disease severity was classified using the Global Initiative for 
COPD (GOLD) criteria: mild, moderate, severe, and very 
severe COPD, defined as FEV1/FVC , 0.7, FEV1 $ 80% 
predicted, FEV1 50%–80% predicted, FEV1 50%–30% pre-
dicted, or FEV1 , 30% predicted, respectively.14
Breathlessness
Breathlessness was measured with the St George’s   Respiratory 
Questionnaire (SGRQ).15 SGRQ is a disease-specific 
questionnaire that measures health status for patients with 
pulmonary disease. The questionnaire consists of 76 items 
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divided into three components: symptoms, activity, and 
impact. A sum is calculated for each component. Each of 
the component scores can range from 0 to 100, with lower 
scores indicating better health status.16–18 The SGRQ has 
been translated into different languages and has satisfactory 
reliability and validity in COPD patients.19–21 As was done in 
previous studies,15,18 the symptom component score was used 
as the measure of breathlessness. The symptom component 
consists of eight items, including frequency and distress 
from breathlessness in terms of phlegm/sputum, shortness 
of breath, wheezing, and chest trouble.15,18 In addition, the 
following individual breathlessness items were evaluated: 
my cough hurts; my cough makes me tired; I get breathless 
when I bend over; my cough or breathing disturbs my sleep; 
and I get exhausted easily. Each item was scored using the 
0 (wrong) versus 1 (right) format. The symptom component 
score, as well as the individual item scores, were used to 
evaluate differences in cough and breathlessness in COPD 
patients with and without pain.
Pain
Patients were categorized into the pain versus no pain groups 
based on their responses to the following question: “Are you 
generally bothered by pain?”
Statistical analyses
Data were analyzed using SPSS (v16.0; SPSS Inc, Chicago, 
IL). Descriptive statistics were used to evaluate demographic, 
clinical, respiratory, and pain variables. Chi-square and 
  independent sample t-tests were used to evaluate for dif-
ferences in demographic and clinical characteristics, and 
respiratory parameters between COPD patients who did and 
did not have pain. Multiple logistic regression analysis was 
done to evaluate the impact of specific respiratory param-
eters (ie, breathlessness and lung function) on pain status 
(ie, having or not having pain) after controlling for clinical 
characteristics (ie, number of comorbidities) that showed 
significant bivariates association with pain. Model fit was 
assessed using the Hosmer and Lemeshow test. A P-value 
of ,0.05 was considered statistically significant.
Results
Of the 136 patients who met the inclusion criteria, 100 
accepted the invitation to participate in this study (response 
rate of 74%). No differences were found in the age (P = 0.60) 
or sex distribution (P = 0.92) of the patients who did and 
did not participate in this study. Of the 100 COPD patients 
who participated in the study, 45% responded “yes” to the 
  question “Are you generally bothered by pain?”
Differences in demographic and clinical 
characteristics between COPD patients 
who did and did not have pain
As shown in Table 1, no significant differences were found 
in any demographic characteristics between COPD patients 
who did and did not have pain. As shown in Table 2, com-
pared to patients without pain, COPD patients with pain 
were more likely to report the presence of a comorbidity 
Table 1 Differences in demographic characteristics between patients with chronic obstructive pulmonary disease who did (N = 45) 
and did not (N = 55) have pain
Demographics COPD patients with pain (N = 45) COPD patients without pain (N = 55) P-value
Mean SD Range Mean SD Range
Age (years) 65.0 9.2 43–83 67.9 7.3 50–80 0.08
N % N %
Sex 0.55
  Male 21 47 30 55
  Female 24 53 25 45
Education 0.71
  Primary school 24 53 25 46
  Secondary school 17 38 22 41
  University 4 9 7 13
Marital status 0.91
  Married/partners 28 64 37 68
  Unmarried 2 4 2 4
  Widow 6 14 8 15
  Divorced/separated 8 18 7 13
Employment status 0.36
  Full or part time 13 29 11 20
  Not employed 32 71 43 80
Abbreviation: COPD, chronic obstructive pulmonary disease.
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Table 2 Differences in clinical characteristics between patients with COPD who did (N = 45) and did not (N = 55) have pain
Characteristics COPD patients with pain (N = 45) COPD patients without pain (N = 55) P-value
Mean SD Range Mean SD Range
Number of comorbidities 2.6 1.9 7–15 1.0 0.87 0–15 ,0.001
Pack years 39.6 29.5 3–140 33.4 20.3 0–100 0.24
Lung function (FEV1% predicted) 47.8 15.8 19–79 44.5 14.3 16–79 0.27
Breathlessness (SgRQ) (0–100) 58.9 25.4 9.8–97.5 42.4 27.7 0.0–93.9 0.003
N % N %
Comorbidity 0.016
  Yes 40 89 36 67
  No 5 11 18 33
Smoking 0.24
  Current smoker 18 44 13 27
  Previous smoker 23 56 35 71
  Never smoked 0 0 1 2
Disease severity 0.09
  Moderate 24 53 20 36
  Severe 14 31 29 53
  Very severe 7 16 6 11
Abbreviations: COPD, chronic obstructive pulmonary disease; FEV1, forced expiratory volume in 1 second; SgRQ, St george’s Respiratory Questionnaire.
Table 3   Comparison  of  prevalence  of  various  comorbid 
conditions between patients with COPD who did (N = 45) and 
did not (N = 55) have pain
Conditions COPD  
patients  




without pain  
(N = 55)
P-values
N % N %
Myocardial infarction 15 33 9 17 0.06
Angina 9 20 7 13 0.42
Stroke 3 7 0 0 0.09
Diabetes 6 13 4 7 0.51
Cancer 7 16 2 4 0.08
Osteoporosis 7 16 2 4 0.08
Fibromyalgia 3 7 0 0 0.09
Chronic pain 10 22 0 0 ,0.001
Rheumatoid arthritis 1 2 0 0 0.46
Osteoarthritis 10 22 4 7 0.05
Ankylosing spondylitis 1 2 0 0 0.46
Skeletal/muscle diseases 11 24 2 4 0.003
Psychiatric diagnosis 5 11 4 7 0.73
gastrointestinal disease 7 16 4 7 0.22
Asthma 20 46 14 28 0.09
Abbreviation: COPD, chronic obstructive pulmonary disease.
(P = 0.016); had a significantly higher number of comorbidi-
ties (P , 0.001); and reported a higher breathlessness score 
on SGRQ (P = 0.003). In terms of self-reported occurrence 
of chronic medical conditions (see Table 3), a higher percent-
age of COPD patients with pain reported chronic pain (22%; 
P , 0.001) and musculoskeletal diseases (24%; P = 0.003) 
compared to those who did not have pain.
Differences in breathlessness between 
COPD patients who did and did not  
have pain
As shown in Figure 1, a significantly higher percentage of 
patients who had pain endorsed the following breathless-
ness items: “my cough makes me hurt” (P = 0.004); “my 
cough makes me tired” (P = 0.006); “my cough or breathing 
disturbs my sleep” (P = 0.001); and “I get exhausted easily” 
(P = 0.027).
Impact of selected variables  
on pain in COPD patients
As shown in Table 4, based on the results of the logistic 
regression analysis, after adjusting for the number of comor-
bidities (OR = 0.28; P = 0.026), greater breathlessness mea-
sured by the SGRQ symptom score (OR = 1.03; P = 0.003) 
was significantly associated with pain, while lung function 
(OR = 1.03; P = 0.052) was nearly significant. The model 
fit showed that number of comorbidities, breathlessness 
and lung function explained 23% (Nagelkerke R-square) 
of the variability in pain. The Hosmer and Lemeshow test 
statistic indicated that goodness of fit to the model was 
satisfactory.
Discussion
This study is the first to evaluate for differences in subjec-
tive and objective respiratory parameters in COPD patients 
with or without pain. It is interesting that after adjusting for 
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Cough hurts
Cough makes me tired
Breathless when I talk









COPD patients without pain
COPD patients with pain
P = 0.027
Figure  1  Differences  in  the  percentages  of  patients  with  chronic  obstructive 
pulmonary disease (COPD) who did (N = 45) and did not (N = 55) have pain 
who endorsed each of the breathlessness items on the St george’s Respiratory 
Questionnaire.
Table 4 Risk factors of pain in patients with chronic obstructive 
pulmonary disease assessed by multiple logistic regression analysis 
(N = 99)
B OR 95% CI P-values
Number of comorbidities −1.13 0.28 0.09–0.86 0.026
Breathlessness  
(SgRQ, 0–100)a
0.03 1.03 1.01–1.05 0.003
Lung function  
(FEV1% predicted)
0.03 1.03 1.00–1.06 0.052
Notes:  The  corresponding  logistic  regression  model  fitted  to  these  data using 
Hosmer and Lemeshow Test. Regression coefficients (B), Adjusted odds ratios (OR) 
(95% confidence interval), and P-values.
Abbreviations:  COPD,  chronic  obstructive  pulmonary  disease;  FEV1,  forced 
expiratory volume in 1 second; SgRQ, St george’s Respiratory Questionnaire.
the number of comorbidities, the COPD patients with pain 
reported significantly higher breathlessness scores compared 
to those who did not report pain. In contrast, similar associa-
tions were not found for pain and the objective measure of 
lung function. These findings are consistent with two previ-
ous reports that used similar measures.5,6 In addition, findings 
across these quantitative studies are consistent with a recent 
qualitative study of COPD patients who were interviewed 
about their pain experiences. Some of these patients described 
their pain as “tying up the body,” which makes it impossible 
to breathe normally and in turn resulted in increased pain.4 
A growing body of evidence suggests that these distinctly 
different sensations share important characteristics. The 
relationship between pain and breathlessness may be partially 
explained by the fact that these sensations are mediated within 
a larger brain network in the anterior insula. Both sensations 
alert the brain and motivate adaptive behaviors.9 Additional 
research is warranted to examine the commonalities and 
differences in these two sensations.
In this study, a significantly higher percentage of COPD 
patients with pain reported that their cough made them hurt, 
that their cough made them tired, that breathlessness/cough 
disturbed their sleep, and that they became exhausted   easily. 
These findings are consistent with a study by   Williams and 
colleagues,22 which found that patients with COPD reported 
that breathlessness was painful, made them tired and weak, 
and led to general exhaustion. Again, the association between 
these respiratory descriptors and pain provide additional 
evidence that breathlessness and pain may share more than 
common cortical pathways.9 Pain is a complex symptom 
that is caused by many different bodily changes.23 COPD 
is a complex progressive lung disease. As the disease pro-
gresses, elastic tissues in the lung are damaged, which leads 
to increased mucous hypersecretion, cough, airway narrow-
ing, decreased oxygen saturation, and breathlessness.14 These 
pathophysiologic changes may lead to pain, sleeplessness, 
fatigue, and exhaustion.4 The disease progresses the airflow 
limitations and decreases in ventilation may increase respi-
ratory muscle work and the work of breathing24,25 which in 
turn may result in fatigue, exhaustion, and pain.4 An equally 
plausible hypothesis is that breathlessness and increased 
muscle work may lead to muscle hypertonicity and fatigue, 
which in turn results in increased ventilatory drive associated 
with greater breathlessness.4,10 A third hypothesis to explain 
the associations between cough, breathlessness, and pain in 
COPD patients is that coughing can lead to pain for mechani-
cal reasons and results in fatigue because it requires energy.4,10 
All of these hypotheses warrant testing in future studies.
Of note, those COPD patients who had pain reported 
a significantly higher number of comorbidities than those 
who did not have pain. In addition, a higher percentage 
of COPD patients with pain reported the occurrence of 
chronic pain and musculoskeletal disorders. As is seen in 
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patients with other chronic medical conditions,26,27 patients 
with COPD may have pain associated with COPD, pain 
associated with other chronic medical conditions, and/or 
pain associated with both their COPD and other chronic 
medical conditions. Additional research is warranted to 
determine the specific and/or multiple etiologies for pain 
in patients with COPD.
A surprising finding was that no differences were found 
in any demographic characteristics (eg, age, sex, education, 
marital status, employment status) between COPD patients 
with and without pain. These findings differ from a   previous 
study of pain in the general Norwegian population,28 which 
found that being younger, being female, having less for-
mal education, living alone, and being unemployed were 
  associated with chronic pain. The reasons for these differ-
ences are not readily apparent and warrant investigation in 
future studies.
Several study limitations need to be acknowledged. 
Because of the relatively small sample size, additional 
differences in both subjective and objective respiratory 
parameters between COPD patients with and without pain 
warrant investigation in future studies. According to the 
biopsychosocial model, pain is associated with physiologic 
as well as psychosocial factors.29–31 Therefore, future studies 
with larger samples may determine additional demographic 
and sociocultural characteristics associated with pain group 
membership. Finally, the COPD patients in this study 
were about to begin a pulmonary rehabilitation program. 
  Therefore, this sample that consisted of patients who had 
primarily moderate to severe COPD, is not a representative 
sample of all COPD patients.
Despite the low sample size in this study, breathless-
ness is associated with pain, which indicates that increased 
breathlessness may result in pain. By striving for greater 
understanding of the relationship between breathless-
ness and pain, the authors suggest that there should be a 
  stronger focus on the relationship between breathlessness 
and pain when precise and effective COPD interventions 
are planned.
Conclusion
In conclusion, the findings from this study suggest that pain 
is a significant problem in patients with COPD. In addition, 
COPD patients who had pain reported a higher number of 
comorbidities and breathlessness than COPD patients who 
did not have pain. Additional research is warranted to more 
completely characterize the causes and multiple   dimensions 
of the pain experience of patients with COPD during   various 
stages of their disease and treatment. A stronger focus on 
the relationship between breathlessness and pain when 
precise and effective COPD interventions are planned is 
recommended.
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